23Jul 2024
HBcrAg Predicts PegIFN-α Treatment Success in CHB

HBcrAg Predicts PegIFN-α Treatment Success in CHB

In chronic hepatitis B patients treated with nucleos(t)ides, pegIFN-α add-on improves T cell responses and HBsAg decline, particularly in those with lower baseline HBcrAg levels. HBcrAg may help identify patients likely to benefit from pegIFN-α therapy.

  • #gastroenterology

Like

Save

Share